MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study

Overview of attention for article published in Biomarker Research, July 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 tweeters

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 10 Mendeley

Summary Twitter Dimensions citations

So far, Dimensions has found 8 publications that cite this research output.

8

The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.

Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA Exploration

Article in International Journal of Molecular Sciences (November 2022)

LINC00893 inhibits the progression of prostate cancer through miR-3173-5p/SOCS3/JAK2/STAT3 pathway

Article in Cancer Cell International (July 2022)

A comprehensive survey into the role of microRNAs in ovarian cancer chemoresistance; an updated overview

Article in Journal of Ovarian Research (July 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.